Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: EMERGE (Study 302) | Statement: [ENGAGE (Study 301), relatedStudy, EMERGE (Study 302)]

Target entity: EMERGE (Study 302)
Context triple: [ENGAGE (Study 301), relatedStudy, EMERGE (Study 302)]

• A. EMERGE (Study 302) chosen
  EMERGE (Study 302) is a pivotal Phase 3 clinical trial designed to evaluate the efficacy and safety of the Alzheimer’s disease drug aducanumab (Aduhelm) in patients with early-stage Alzheimer’s.
• B. ENGAGE (Study 301)
  ENGAGE (Study 301) is a large Phase 3 clinical trial designed to evaluate the efficacy and safety of the anti-amyloid monoclonal antibody aducanumab (Aduhelm) in patients with early Alzheimer’s disease.
• C. APHINITY trial
  The APHINITY trial is a large phase III clinical study that evaluated the addition of pertuzumab (Perjeta) to standard trastuzumab-based adjuvant therapy in patients with HER2-positive early breast cancer.
• D. CLEOPATRA trial
  The CLEOPATRA trial was a pivotal phase III clinical study that demonstrated improved survival by adding pertuzumab (Perjeta) to trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.
• E. ENSEMBLE trial
  The ENSEMBLE trial was a large, global Phase 3 clinical study designed to evaluate the safety and efficacy of Janssen’s single-dose COVID-19 vaccine in preventing SARS-CoV-2 infection and severe disease.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target predicate: relatedStudy
Context triple: [ENGAGE (Study 301), relatedStudy, EMERGE (Study 302)]

• A. studiedAlongWith
  Indicates that two or more entities engaged in studying the same subject or course together during the same time period.
• B. studiedWithin
  Indicates that one entity pursued studies or academic work within the scope, context, or boundaries defined by another entity (such as an institution, program, or field).
• C. associatedScholar
  Indicates a relationship where a scholar is linked or connected to another entity (such as a work, institution, or concept) through relevant academic or intellectual involvement.
• D. studiesConcept
  Indicates that an entity engages in learning, examining, or researching a particular concept.
• E. relatedTest
  Indicates that there exists some form of connection or association between one test and another.
• F. None of above. chosen